Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data

OBJECTIVE: Several predictors of survival have been identified in EGFR-positive non-small cell lung cancer (NSCLC) patients treated with first generation EGFR inhibitors. Prognostic models of survival outcomes with afatinib have not been evaluated. METHODS: A prognostic tool for overall survival (OS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopkins, Ashley M., Shahnam, Adel, Zhang, Sasha, Karapetis, Chris S., Rowland, Andrew, Sorich, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713630/
https://www.ncbi.nlm.nih.gov/pubmed/31516754
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713630/
https://www.ncbi.nlm.nih.gov/pubmed/31516754
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0474

Ejemplares similares